Comparison of pharmacologic agents to treat GDM
Insulin or an oral antihyperglycemic agent? Get the expert information you need to make the correct call.
A survey of MFM specialists published in 2017 reported that 57% use glyburide as their first-line treatment for gestational diabetes mellitus (GDM), 36% use insulin and 4% use metformin.
Read more on hyperglycemia in gestational diabetes: Using oral antidiabetic agents to manage hyperglycemia in GDM
References:
Bimson BE, Rosenn BM, Morris SA, Sasso EB, Schwartz RA, Brustman LE. Current trends in the diagnosis and management of gestational diabetes mellitus in the United States. J Matern Fetal Neonatal Med. 2017;30(21):2607-2612.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
